JO
CDLX icon

John Overdeck’s Cardlytics CDLX Stock Holding History

John Overdeck’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,375
Closed -$326K – 4622
2025
Q4 		$326K Buy
28,375
+15,781
+125% +$244K ﹤0.01% 3537
2025
Q3 		$306K Buy
12,594
+3,890
+45% +$64.8K ﹤0.01% 3202
2025
Q2 		$143K Sell
8,704
-1,455
-14% -$25.1K ﹤0.01% 2964
2025
Q1 		$185K Buy
10,159
+669
+7% +$19.1K ﹤0.01% 2869
2024
Q4 		$352K Buy
9,490
+1,051
+12% +$40.2K ﹤0.01% 2679
2024
Q3 		$270K Sell
8,439
-7,443
-47% -$413K ﹤0.01% 2715
2024
Q2 		$1.3M Sell
15,882
-879
-5% -$95K ﹤0.01% 1835
2024
Q1 		$2.43M Buy
16,761
+11,411
+213% +$963K 0.01% 1346
2023
Q4 		$493K Buy
5,350
+270
+5% +$27.4K ﹤0.01% 2469
2023
Q3 		$838K Hold
5,080
– – ﹤0.01% 2033
2023
Q2 		$321K Sell
5,080
-54,212
-91% -$3.28M ﹤0.01% 2493
2023
Q1 		$2.01M Sell
59,292
-5,032
-8% -$263K 0.01% 1377
2022
Q4 		$3.72M Buy
64,324
+20,765
+48% +$1.28M 0.01% 998
2022
Q3 		$4.09M Buy
43,559
+24,935
+134% +$3.55M 0.01% 829
2022
Q2 		$4.16M Buy
18,624
+18,104
+3,482% +$6.06M 0.01% 852
2022
Q1 		$286K Sell
520
-9,885
-95% -$5.97M ﹤0.01% 2226
2021
Q4 		$6.88M Buy
10,405
+10,065
+2,960% +$7.69M 0.01% 1013
2021
Q3 		$285K Sell
340
-600
-64% -$609K ﹤0.01% 3714
2021
Q2 		$1.19M Sell
940
-3,796
-80% -$4.28M ﹤0.01% 2325
2021
Q1 		$5.2M Buy
+4,736
New +$6.25M 0.01% 1021
2020
Q2 		– Sell
-6,397
Closed -$2.24M – 2990
2020
Q1 		$2.24M Sell
6,397
-3,539
-36% -$2.51M 0.02% 910
2019
Q4 		$6.25M Buy
9,936
+8,726
+721% +$4.27M 0.02% 830
2019
Q3 		$406K Buy
+1,210
New +$388K ﹤0.01% 2718
2018
Q4 		– Sell
-3,799
Closed -$951K – 3024
2018
Q3 		$951K Buy
3,799
+269
+8% +$57.9K ﹤0.01% 2013
2018
Q2 		$768K Buy
3,530
+1,129
+47% +$209K ﹤0.01% 2338
2018
Q1 		$351K Buy
+2,401
New +$406K ﹤0.01% 2696

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

John Overdeck's CDLX Position: Q1 2026 in Review

John Overdeck sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 28,375 shares — an estimated $326K sold.

John Overdeck first reported a position in CDLX in Q1 2018 and held it in 26 quarters. The position peaked at $6.88M in Q4 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • John Overdeck reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 28,375 Cardlytics shares in Q1 2026, an estimated $326K.
  • John Overdeck first reported a position in Cardlytics in Q1 2018 and held it in 26 quarters.
  • John Overdeck's Cardlytics position peaked at $6.88M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.